THC Farmaceuticals Signs Contract to Acquire CBDual Biotechnology

Author's Avatar
Apr 12, 2019
Article's Main Image

THOUSAND OAKS, CA / ACCESSWIRE / August 22, 2018 / THC Farmaceuticals, Inc. (OTC PINK: CBDG) today announced the signing of a definitive agreement to acquire a majority ownership of CBDual Biotechnology Corp. CBDual is a pharmaceutical start-up company focused on developing products based on cannabidiol (CBD). The company facility is located in southern California, providing easy access for patients to participate in clinical trials of new medical cannabis medications, therapies, and products.